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Intraperitoneal analgesia for laparoscopic
cholecystectomy
Abstract
Background and Purpose: Although postoperative pain after laparo-
scopic cholecystectomy is less than open cholecystectomy, many patients still
require strong analgesia postoperatively. Intraperitoneal administration of
local anaesthetics alone or in combination with opioids can effectively con-
trol postoperative pain. The purpose of this study was to assess the analgesic
effect of the intraperitoneal administration of bupivacaine and/or tramadol
in patients undergoing laparoscopic cholecystectomy.
Patients and Methods: For this study, 144 patients undergoing laparo-
scopic cholecystectomy were randomized in one of four groups: Group C re-
ceived 50 ml of saline, Group T received 50 ml of saline containing 100 mg
tramadol, Group B received 50 ml of 0.25% bupivacaine while patients al-
located to Group TB received 50 ml of 0.25% bupivacaine with 100 mg of
tramadol intraperitonealy. Visual analogue scale was recorded half and
hours, 1, 2, 4, 6 and 24 hours postoperatively. Incidence of postoperative
nausea and vomiting (PONV) was also recorded. In addition, supplemen-
tary analgesic and antiemetic consumption were assessed.
Results: Pain intensity, PONV as well as postoperative supplementary
medications were significantly lower in Group T, Group B and Group TB
than in Group C. There were no differences between the three groups re-
ceiving tramadol and/or bupivacain in VAS score, incidence of nausea and
vomiting and postoperative analgesic and antiemetic consumption.
Conclusion: Intreperitoneal instillation of tramadol and/or bupivacai-
ne is an effective method for management of postoperative pain after lap-
aroscopic cholecystectomy. It significantly reduced supplementary postoper-
ative analgesic and antiemetic medication.
INTRODUCTION
Laparoscopic cholecystectomy results in less postoperative pain ascompared with open cholecystectomy, and pain may be mild or
moderate or even severe for some patients. After laparoscopic chole-
cystectomy patients complain more of visceral pain as a result of stretch-
ing of the intraabdominal cavity, peritoneal inflammation and phrenic
nerve irritation caused by residual carbon dioxide in the peritoneal cav-
ity, whereas after open cholecystectomy the type of pain results mostly
in parietal pain (1). Postoperative abdominal pain usually occurs dur-
ing the first 24 hours, while shoulder pain most commonly appears the
second day after laparoscopic cholecystectomy. Intraperitoneal (IP) ad-
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Clinical experience
aroscopic surgery. Some authors suggest that intraperito-
neal instillation of drugs for pain relief is effective if used
before creation of pneumoperitoneum (2) while others
conclud that intraperitoneal drug administration is effec-
tive at the end of the surgery applied through a trocar (3).
The aim of this study was to evaluate the effect of in-
traperitoneal administration of tramadol and/or bupiva-
caine on pain relief in patients undergoing laparoscopic
cholecystectomy.
PATIENTS AND METHODS
Before surgery all patients included in the study signed
informed consent that was approved by the local ethic
committee. One hundred and forty- four patients of ASA
I, II and III status undergoing elective laparoscopic chole-
cystectomy for cholelithiasis were included in the study.
Patients with contraindications to tramadol or bupiva-
caine, those who had to be converted to open cholecystec-
tomy were excluded from the study. Standard operative
method was used as described (4). For each patient demo-
graphic, perioperative and postoperative details were noted.
Patients were randomly assigned by a computer gen-
erated table into one of four groups. Patient allocated to
Group C received 50 ml of saline IP, Group T received 50
ml of saline containing 100 mg tramadol, Group B re-
ceived 50 ml of 0.25% bupivacaine while patients allo-
cated to Group TB received 50 ml of 0.25% bupivacaine
with 100 mg of tramadol. The surgeons did not known
the treatment group until the end of the study.
Thirty minutes before surgery all patents received
midazolam (7.5 mg orally per patient). General anesthe-
sia was induced by intravenously administration of su-
fentanil (0.15–0.3 mg/kg) and propofol (2.5–3 mg/kg).
Orotracheal incubation was facilitated by rocuronium
(0.6 mg/kg i.v.). After intubation the patients were venti-
lated with intermittent positive-pressure ventilation by
using a mixture of 1.5–2% sevoflurane, oxygen and air.
Minute ventilation was adjusted to keep end-tidal pCO2
at 4.5–5.5 kPa.
Fifteen minutes before the end of the surgery the pa-
tients received drugs, according to their allocation to the
group, into the hepatodiaphragmatic space, near and
above the hepato-duodenal ligament and above the gall
bladder bed under direct vision. All patients stayed in
PACU after surgery for two hours. The intensity of the
pain was recorded for all patients using visual analogue
score (VAS) at 0.5, 1, 2, 4, 6 and 24 hours after surgery.
Analgesia requirements were also recorded. If the VAS
score was greater than 3, the patient was prescribed opioid
(meperidine 50 mg i.v.). If the VAS score was below 3
nonsteroidal anti-inflammatory drugs (NSAID; diclofe-
nac: 75 mg i.v.) was prescribed. Data were collected on
the occurrence of postoperative nausea and vomiting.
For the patients who experienced PONV, metoclopra-
mide (10 mg) was given intravenously.
To calculate the sample size, we considered the results of
our previous study (5). A total of 35 patients for each group
were required to detect the designed difference in the VAS
score, accepting a two tail a error of 5% and b error of 20%.
Results are reported as mean +/– SD. Data were ana-
lyzed by two-way analysis of variance. Demographic
data were studied using Student’s t-test, whereas differ-
ences in the incidence of PONV were studied using
chi2test. Pain score for both groups were compared using
the Kruscal-Walis and Mann-Whitney U-test. Results
were considered statistically significant at the 5% critical
level (p<0.05). Data were analyzed with the statistical
programme Statistica for Windows version 7.1 (StatSoft
Inc, Tulsa, USA).
RESULTS
For this study, 144 patients were recruited. They were
divided into four groups. There were no significant diffe-
rences between groups according to sex, age, body weight
and duration of operation (Table 1). No serious side-ef-
fects occurred in any group of patients.
The mean intensity of postoperative pain was signifi-
cantly lower in Group B, Group T and Group TB than
in Group C 0.5, 1, 2, 4, and 6 hours after the operation
(p<0.05) (Figure 1). There was no statistically signifi-
cant difference in VAS score between Group B, Group T
and Group TB at all time points (Figure 1).
The supplementary postoperative medication require-
ment was significantly higher in the control group com-
pared to all other groups. Five patients in Group T, 6 pa-
tients in Group B and only 3 patients in Group TB
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TABLE 1
Data from 144 patients who received IP saline (group C), tramadol (group T), bupivacaine (group B) or bupivacaine with
tramadol (group TB) during laparoscopic surgery. Values are mean ±SDa. Data of supplementary postoperative medica-









Sex ratio (F:M) 19:17 20:15 20:17 21:15
Agea (years) 54.1±12.3 53.4±10 52.5±11.2 53.8±11.1
Body weighta (kg) 74.2±11.1 71.3±12 76.3±11 75.5±13
Duration of operationa (min) 72.8±16.5 74.6±22 75.5±18 73.3±21.1
required NSAID for pain relief. Opioid consumption
was recorded only in Group C (Table 2). A considerably
high number of the patients in Group C received anti-
emetic drug (metoclopramide was required by 32 pa-
tients in Group C, 4 patients in Group T, 2 patients in
Group B and only one in Group TB; p<0.05) (Table 2).
In Group C thirty- five patients experienced nausea
and 16 patients vomited, whereas 6 patients in Group T
and Group B and 3 patients in Group TB had nausea
while 3 patients in Group T, 2 patients in Group B and
only one patient in Group TB experienced vomiting
(p<0.05) (Table 3).
DISCUSSION
In our study we showed that intraperitoneal adminis-
tration of bupivacaine and/or tramadol resulted in much
lower pain scores, the incidence of PONV and less sup-
plementary analgesic consumption in patients undergo-
ing laparoscopic cholecystectomy.
Over a decade, clinical trails were designed to deter-
mine the benefit of local anaesthetics and opioids, pre-
sumably bupivacaine and morphine, administrated in-
traperitoneally after laparoscopic cholecystectomy. Some
investigators found that IP bupivacaine was effective in
pain reduction, while others showed that it did not atten-
uate pain following laparoscopic surgery (6, 7, 8, 9, 10).
Hernandes-Palazon et al. found that IP administra-
tion of local anaesthetic (bupivacaine) in combination
with an opioid (morphine) reduced the analgesic re-
quirements during the first 6 postoperative hours, and
that a combination is more effective for treatment of pain
after laparoscopic cholecystectomy (11).
Recently, Akinci et al. showed that intravenous trama-
dol provides superior postoperative analgesia compared
with an equivalent dose of tramadol administrated intra-
peitoneally in patients undergoing laparoscopic chole-
cystectomy (12). On the contrary, Memis et al. found that
intraperitoneal tramadol and bupivacaine are very effec-
tive for postoperative analgesia in patients undergoing
laparoscopic tube ligation (13).
In our previous study we found that intraperitoneal
administration of tramadol had valuable implication in
reducing pain for patients undergoing laraposcopic cho-
lecystectomy (5).
This study showed that intraperitoneal application of
tramadol or bupivacaine alone or in combination re-
duced pain for the first six hours after surgery. It also
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TABLE 2
Data of supplementary postoperative medications in pa-
tients studied. *p<0.05 was considered statistically sig-
nificant.
Medications Group C Group T Group B Group TB
NSAID 35* 5 6 3
opioids 30* 0 0 0
metoclopramide 32* 4 2 1
TABLE 3
Nausea and vomiting frequencies in patients studied.











35* 6 6 3
Number of patients
with vomiting
16* 3 2 1
Figure 1. The effect of IP bupivacaine and bupivacine with tramadol on pain using visual analog scale (VAS) at 0.5, 1, 2, 4, 6 and 24 hours after sur-
gery. Values are mean ±SD. *p<0.05 was considered statistically significant.
helped to decrease postoperative non-steroid drug and
opiate consumption. Intraperitoneal administration of
tramadol and/or bupivacaine significantly reduced nau-
sea and vomiting which helped realization of earlier re-
covery and discharge from the hospital. This finding has
demonstrated that both drugs are equally effective and
safe for patients undergoing laparoscopic procedures.
In conclusion, intraperitoneal analgesia with bupiva-
caine or tramadol alone or in combination is simple to
use and effective in a reduction of pain and therefore rec-
ommended in patients undergoing laparoscopic chole-
cystectomy.
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